Back

P2Y12 platelet receptor inhibition and risk of ischemic stroke after coronary drug-eluting stents: the ADAPT-DES study

30 August 2016 (08:30 - 12:30)
Organised by:
Congress Presentation Part of: Best Posters session 6 - Best Posters in PCI and beyond PCI: procedural complications ESC Premium Access ESC Congress 2016

About the speaker

Photo
Doctor Gennaro Giustino

Mount Sinai Hospital, New York (United States of America)

4 More presentations in this session

Presentation thumbnail
Presentation thumbnail
Doctor R. Pracon (Warsaw, PL)
Abstract Slides
Presentation thumbnail
Doctor J. Honek (Prague, CZ)
Abstract Slides
Presentation thumbnail
Doctor M. Andreassi (Pisa, IT)
Abstract

Access the full session

Session thumbnail
Best Posters session 6 - Best Posters in PCI and beyond

The Event

Event poster

ESC Congress 2016

30 August 2016 08:30 CET
You may be interested in
thumbnail
Congress Session
Dual antiplatelet therapy titration after percutaneous coronary intervention: when to escalate, de-escalate, withdraw, and more
28 August 2023
thumbnail
Congress Presentation
Titanium-nitride-oxide-coated vs drug-eluting stents in acute coronary syndromes during five-year follow-up: an individual patient data meta-analysis
31 August 2024
thumbnail
Congress Presentation
Efficacy and safety of P2Y12 inhibitors plus aspirin versus aspirin alone in ischemic stroke or high-risk transient ischemic attack: a meta-analysis of randomized controlled trials
2 September 2024
thumbnail
Congress Session
State-of-the-art antithrombotic treatment in acute coronary syndromes: a paradigm shift?
14 March 2025

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources